The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

According to The Business Research Company’s Antisense & RNAi Therapeutics Global Market Report 2023, the antisense & RNAi therapeutics market is expected to show promising growth in the forecast period.

Five Key insights from the forecast include:

1. Market Size – The global antisense & RNAi therapeutics market size is expected to grow from $1.42 billion in 2022 to $1.54 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The market size of the antisense & rnai therapeutics is expected to grow from $2.42 billion in 2027 at a CAGR of 12.0%.
2. Major Driver – The rising prevalence of coronary artery diseases, neurodegenerative disorders, and infectious diseases is projected to contribute to the demand for the antisense & RNAi therapeutics market.
3. Key Trend – Major companies operating in the antisense & RNAi therapeutics market are undertaking strategic initiatives such as collaborations and partnerships for product innovation to sustain in the increasingly competitive market, companies are developing innovative products as well as sharing skills and expertise with other companies.
4. Largest Region – North America was the largest region in the antisense & RNAi therapeutics market in 2022.
5. Major Players – Major players in the antisense & RNAi therapeutics market are Alnylam Pharmaceuticals, Benitec Biopharma Ltd., Gene Signal, GlaxoSmithKline PLC., Ionis Pharmaceuticals, Marina Biosciences.

View More On The Antisense & RNAi Therapeutics Market Report 2023 – https://www.thebusinessresearchcompany.com/report/antisense-and-rnai-therapeutics-global-market-report

Key Antisense & RNAi Therapeutics Market Segments
The global antisense & RNAi therapeutics market is segmented –
1) By Technology: RNA Interference, Antisense RNA
2) By Route of Administration: Pulmonary Delivery, Intravenous Injections, Intra-dermal Injections, Intraperitoneal Injections, Topical Delivery, Other Delivery Methods
3) By Indication: Oncology, Cardiovascular Diseases (CVDs), Respiratory Disorders, Neurological Disorders, Infectious Diseases, Other Indications

Request A Sample Of The Global Antisense & RNAi Therapeutics Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=3389&type=smp

Antisense therapy refers to the selective, sequence-specific suppression of gene expression by single-stranded DNA oligonucleotides. Contrarily, RNA interference (RNAi) is activated by double-stranded RNA (dsRNA) and results in the sequence-specific mRNA degradation of single-stranded target RNAs.

The Antisense & RNAi Therapeutics Global Market Report 2023  offers a comprehensive overview on the antisense & RNAi therapeutics market size, growth rate, trends and drivers, opportunities, strategies, and competitor landscape. The countries covered in the antisense & RNAi therapeutics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The Table Of Content For The Antisense & RNAi Therapeutics Market Include:
1. Antisense & RNAi Therapeutics Market Executive Summary
2. Antisense & RNAi Therapeutics Market Segments
3. Antisense & RNAi Therapeutics Market Size And Antisense & RNAi Therapeutics Market Growth Rate
4. Key Antisense & RNAi Therapeutics Market Trends
5. Major Antisense & RNAi Therapeutics Market Drivers
……
25. Key Mergers And Acquisitions In The Antisense & RNAi Therapeutics Market
26. Top Antisense & RNAi Therapeutics Companies
27. Antisense & RNAi Therapeutics Market Opportunities And Strategies
28. Antisense & RNAi Therapeutics Market, Conclusions And Recommendations
29. Appendix

View More Related Reports –
AntiParkinson Drugs Global Market Report 2023
Antiobesity Global Market Report 2023
AntiHypertensive Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model